Company · St-Maur-Des-Fosses, Val-De-Marne, France
Septodont
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 29
- 17 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 19
- 9 active
- Notices of Compliance
- 10
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - N | 02561980 | Marketed | |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - SP | 02561999 | Marketed | |
| CARBOCAINE 3% | 02474174 | Marketed | |
| LIDOCAINE 2% AND EPINEPHRINE 1:100,000 | 02473518 | Marketed | |
| LIDOCAINE 2% AND EPINEPHRINE 1:50,000 | 02473526 | Marketed | |
| LIGNOSPAN FORTE | 00375799 | Marketed | |
| LIGNOSPAN STANDARD | 00375780 | Marketed | |
| MARCAINE | 02474247 | Marketed | |
| ORAVERSE | 02421666 | Marketed | |
| SCANDONEST 3% PLAIN INJ | 00479934 | Marketed | |
| SEPTANEST N | 02123371 | Marketed | |
| SEPTANEST SP | 02123398 | Marketed | |
| XYLONOR | 02218607 | Marketed | |
| XYLONOR GEL | 00479896 | Marketed | |
| SCANDONEST 2% SPECIAL INJ | 00479942 | Dormant | |
| VIVACAINE | 02305135 | Dormant | |
| ZORCAINE | 02474239 | Dormant | |
| ALVOGYL | 00555509 | Cancelled Post Market | |
| CAUSTINERF | 00229644 | Cancelled Post Market | |
| CRESOPHENE LIQ | 00379689 | Cancelled Post Market | |
| ENDOMETHASONE IVORY | 00229679 | Cancelled Post Market | |
| ENDOPEROX 100% | 00794163 | Cancelled Post Market | |
| LARGAL ULTRA | 00229636 | Cancelled Post Market | |
| LIGNOSPAN SPECIALE INJ | 00405221 | Cancelled Post Market | |
| PHARMAETHYL AER | 00319244 | Cancelled Post Market | |
| RACESTYPTINE CORD | 00379646 | Cancelled Post Market | |
| RACESTYPTINE SOL | 00379638 | Cancelled Post Market | |
| SEPTOMIXINE FORTE | 00229652 | Cancelled Post Market | |
| XYLONOR SPRAY | 00319317 | Cancelled Post Market |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| BIODENTINE XP | 108023 | Issued (active) · Class 3 | |
| BIOROOT FLOW | 107703 | Issued (active) · Class 3 | |
| ULTRA SAFETY PLUS TWIST XL | 105474 | Issued (active) · Class 2 | |
| BIOROOT RCS | 97888 | Issued (active) · Class 3 | |
| ALVEOGYL | 95953 | Issued (active) · Class 2 | |
| BIODENTINE | 87510 | Issued (active) · Class 3 | |
| ULTRA SAFETY PLUS XL NEEDLE | 67612 | Issued (active) · Class 2 | |
| SEPTOJECT XL | 65438 | Issued (active) · Class 2 | |
| SEPTOJECT | 35836 | Issued (active) · Class 2 | |
| ENDOSOLV | 98753 | Discontinued at renewal · Class 2 | |
| ENDOSOLV R | 94462 | Cancelled · Class 2 | |
| ENDOSOLV E | 93313 | Cancelled · Class 2 | |
| ENDOMETHASONE N + ENDOMETHASONE LIQUID | 91159 | Discontinued at renewal · Class 3 | |
| R.T.R. (RESORBABLE TISSUE REPLACEMENT) SYRINGE | 90845 | Discontinued at renewal · Class 3 | |
| RACEGEL | 90119 | Discontinued at renewal · Class 2 | |
| ACROSEAL | 87487 | Discontinued at renewal · Class 3 | |
| PROVISCELL | 20333 | Discontinued at renewal · Class 2 | |
| KIT PARCAN | 19579 | Discontinued at renewal · Class 2 | |
| CIMPAT | 14728 | Cancelled · Class 3 |
Notices of Compliance
Newest first.
- ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - N; ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - SPOctober 14, 2025 · NOC 36160 · New Drug Submission (NDS)
- SEPTANEST N; SEPTANEST SPJanuary 29, 2025 · NOC 34755 · Supplement to a New Drug Submission (SNDS)
- VIVACAINEJanuary 23, 2025 · NOC 34742 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SEPTANEST N; SEPTANEST SPNovember 16, 2021 · NOC 27042 · Supplement to a New Drug Submission (SNDS)
- ZORCAINEMarch 26, 2018 · NOC 20663 · New Drug Submission (NDS)
- MARCAINEMarch 26, 2018 · NOC 20664 · Abbreviated New Drug Submission (ANDS)
- VIVACAINEJune 21, 2017 · NOC 19452 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRILOCAINE HYDROCHLORIDE INJECTION, USP, 4%December 8, 2014 · NOC 16417 · Abbreviated New Drug Submission (ANDS)
- ORAVERSEFebruary 26, 2014 · NOC 15334 · New Drug Submission (NDS)
- VIVACAINE (BUPIVACAINE HCL 0.5% & EPINEPHRINE 1:200,000 INJ, USP)February 12, 2008 · NOC 9370 · Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- OraVerse: Distribution to wholesalers who do not hold an establishment license for sale of the product in CanadaNovember 13, 2025 · Drugs · Establishment/Site licensing · Type III
- OraVerse: Six wholesalers do not hold an establishment license for sale of the product in CanadaNovember 1, 2023 · Drugs · Establishment/Site licensing · Type III
- OraVerse Injection (2018-04-20)April 27, 2018 · Drugs · Product safety · Type III
- Oraverse (2015-01-02)January 14, 2015 · Drugs · Product safety · Type III
- Lignospan Standard and Oraverse (2014-12-12)December 23, 2014 · Drugs · Product safety · Type I